The MycetOS (Mycetoma Open Source) project was launched today by the University of Sydney, Erasmus MC, and the Drugs for Neglected Diseases initiative (DNDi) to use an Open Pharma approach to discover compounds that could lead to new treatments for patients suffering from fungal mycetoma (eumycetoma), a devastating disease for which current treatments are ineffective, expensive, and toxic.
University of Sydney
See the following -
Australian High School Students Use Open Source to Make Shkreli's $750 Drug For Less Than $2
Press Release |
University of Sydney |
November 30, 2016
Sydney Grammar students, under the supervision of the University of Sydney and global members of the Open Source Malaria consortium, have reproduced an essential medicine in their high school laboratories. The drug, Daraprim, had been the subject of controversy when the price was hiked from US$13.50 to US$750 a dose last year. Daraprim - originally used as an antimalarial after its synthesis by Nobel Prize winner Gertrude Elion - is now more widely used as an anti-parasitic treatment for toxoplasmosis, which can be a dangerous disease for pregnant women and people with compromised immune systems, such as those living with HIV or AIDS...
- Login to post comments
Australian Students Recreate Martin Shkreli Price-Hike Drug in School lab
Play VideoPlay Current Time 0:00 / Duration Time 0:49 Loaded: 0% Progress: 0% FullscreenMute Sydney students recreate life-saving drug that had 5,000% price hike Melissa Davey | The Guardian | November 30, 2016
A group of Australian high school students have managed to recreate a life-saving drug that rose from US$13.50 to US$750 a tablet overnight after an unscrupulous price-hike by former hedge fund manager Martin Shkreli. The Sydney Grammar students reproduced the drug, Daraprim, used to treat a rare but deadly parasitic infection, in their high school laboratory with support from the University of Sydney and global members of the Open Source Malaria consortium...
- Login to post comments
Breaking Good: School Students Make Costly Drug Cheaply Using Open Source Approach
Press Release |
University of Sydney |
November 30, 2016
Sydney Grammar students, under the supervision of the University of Sydney and global members of the Open Source Malaria consortium, have reproduced an essential medicine in their high school laboratories. The drug, Daraprim, had been the subject of controversy when the price was hiked from US $13.50 to US$750 a dose last year. Daraprim - originally used as an antimalarial after its synthesis by Nobel Prize winner Gertrude Elion - is now more widely used as an anti-parasitic treatment for toxoplasmosis, which can be a dangerous disease for pregnant women and people with compromised immune systems, such as those living with HIV or AIDS...
- Login to post comments
International Team of Scientists Open Sources Search for Malaria Cure
By Alice Williamson | June 21, 2014
The Open Source Malaria (OSM) project operates along very similar lines to traditional medicinal chemistry projects in that the team is looking for an antimalarial drug candidate suitable for Phase 1 clinical trials. However, the day to day running of the project works quite differently and is probably most clearly defined by the team’s commitment to The Six Laws of Open Science... Read More »
- Login to post comments
Martin Shkreli Congratulates Australian Students for Recreating Life-Saving Drug
Staff Writer | Fortune | December 2, 2016
Former pharmaceutical executive Martin Shkreli has congratulated a group of Australian students who reproduced the active ingredient for a life-saving, anti-parasitic drug at the centre of a drug-price controversy involving his former company. The students from Sydney Grammar School drew global media attention this week after they said they had produced the drug Daraprim for about $2 a dose, a fraction of the current list price of $750 per dose. Shkreli is a former chief executive of Turing Pharmaceuticals, where he sparked outrage among patients and U.S. lawmakers for raising the price of Daraprim by more than 5,000%...
- Login to post comments
New Open Source Drug Discovery Project Aims to Develop Mycetoma Treatment
Press Release |
ErasmusMC , University of Sydney , DNDi |
February 6, 2018
- Login to post comments
Open Data Key To Tackling Neglected Tropical Diseases
By Laura Owings | June 17, 2015
Open data access could promote collaborations among researchers in Africa and help in the fight against malaria, tuberculosis (TB) and neglected tropical diseases such as sleeping sickness, also called African trypanosomiasis. At a time when demand for open data in health and drug discovery is dominating the digital space, some researchers say the model could work for Africa and alleviate the sufferings of many from these diseases. Following the call on 23 April this year from the WHO for the disclosure of all results from clinical trials of new medicines, there is a push towards greater transparency.
- Login to post comments
Open source bionic leg: First-of-its-kind platform aims to rapidly advance prosthetics
Press Release |
Michigan Engineering |
June 5, 2019
A new open-source, artificially intelligent prosthetic leg designed by researchers at the University of Michigan and Shirley Ryan AbilityLab is now available to the scientific community. The leg's free-to-copy design and programming are intended to improve the quality of life of patients and accelerate scientific advances by offering a unified platform to fragmented research efforts across the field of bionics. "Our Open-Source Bionic Leg will enable investigators to efficiently solve challenges associated with controlling bionic legs across a range of activities in the lab and out in the community," said lead designer Elliott Rouse, core faculty at U-M's Robotics Institute and assistant professor of mechanical engineering.
- Login to post comments
Copyright ©2011-2020 Open Health Marketplace, LLC. All Rights Reserved.